NOX4 Signaling Mediates Cancer Development and Therapeutic Resistance through HER3 in Ovarian Cancer Cells
Development of resistance to therapy in ovarian cancer is a major hinderance for therapeutic efficacy; however, new mechanisms of the resistance remain to be elucidated. NADPH oxidase 4 (NOX4) is responsible for higher NADPH activity to increase reactive oxygen species (ROS) production. In this stud...
Main Authors: | Wen-Jing Liu, Ying-Xue Huang, Wei Wang, Ye Zhang, Bing-Jie Liu, Jian-Ge Qiu, Bing-Hua Jiang, Ling-Zhi Liu |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-06-01
|
Series: | Cells |
Subjects: | |
Online Access: | https://www.mdpi.com/2073-4409/10/7/1647 |
Similar Items
-
ROS and miRNA Dysregulation in Ovarian Cancer Development, Angiogenesis and Therapeutic Resistance
by: David C. Stieg, et al.
Published: (2022-06-01) -
HER2 regulates HIF-2α and drives an increased hypoxic response in breast cancer
by: Edward J. Jarman, et al.
Published: (2019-01-01) -
Serum HER2 Level in Epithelial Ovarian Cancer
by: Ahmad Monabati, et al.
Published: (2010-04-01) -
HVEM/HIF-1α promoted proliferation and inhibited apoptosis of ovarian cancer cells under hypoxic microenvironment conditions
by: Liyan Duan, et al.
Published: (2020-04-01) -
Polydatin Ameliorates High Fructose-Induced Podocyte Oxidative Stress via Suppressing HIF-1α/NOX4 Pathway
by: Hong Ding, et al.
Published: (2022-10-01)